CNL Strategic Residential Credit Updates Net Asset Value Per Share
CNL Strategic Residential Credit, Inc. updates net asset value per share for Class FA and Class E shares, effective October 30, 2026.
Kinetik Holdings settles NGL purchase agreement dispute
Kinetik Holdings Inc. settles a dispute with Energy Transfer over an NGL purchase agreement, confirming its expiration date as December 31, 2026.
Mirum Pharmaceuticals Reports Positive Results for ATEBRIOZ
Mirum Pharmaceuticals shares positive results from the PROGRESS study for ATEBRIOZ in pediatric patients with fibrodysplasia ossificans progressiva.
Standex International appoints new director, Brenna Preisser
Standex International Corporation announces Brenna D. Preisser as a new board member, succeeding B. Joanne Edwards, effective January 1, 2027.
Soren Acquisition Corp. announces leadership transition
Soren Acquisition Corp. implements leadership changes, appointing new directors and a CFO to enhance governance and operational strategy.
Genvor Inc Signs Key Intellectual Property Agreement
Genvor Inc has entered into an Intellectual Property Assignment Agreement with Dr. Jesse Jaynes, enhancing its R&D capabilities in agricultural production.
Praetorian Acquisition Corp. announces leadership changes
Praetorian Acquisition Corp. undergoes a leadership transition with new directors and a CFO, impacting its governance and the blank check industry.
Churchill Capital Corp XIII appoints Paul Lapping to board
Churchill Capital Corp XIII has appointed Paul Lapping as a director, enhancing its leadership in the blank check industry.
Cumberland Pharmaceuticals to Submit New Drug Application for Ifetroban
Cumberland Pharmaceuticals plans to submit a New Drug Application for ifetroban, targeting cardiomyopathy in Duchenne muscular dystrophy patients.
Bain Capital Private Credit Announces Unregistered Share Sale
Bain Capital Private Credit reports the sale of unregistered Class I common shares, indicating strong investor interest in private credit.
CV Sciences settles arbitration with former legal counsel
CV Sciences, Inc. settles arbitration with former legal counsel for $500,000, enhancing its financial position and focusing on core operations.
Columbus McKinnon Declares Quarterly Dividend of $0.07
Columbus McKinnon Corp announces a quarterly dividend of $0.07 per share, reflecting its commitment to shareholder value and financial stability.
Supernus Pharmaceuticals terminates UBS Credit Line ahead of merger
Supernus Pharmaceuticals ends UBS Credit Line as it prepares for merger with Indivior Pharmaceuticals, signaling a shift in financial strategy.
Flexsteel Industries Reports First Quarter Results for 2026
Flexsteel Industries Inc. announces its first-quarter results for fiscal 2026, shedding light on its operational performance and financial health.
GrafTech updates costs for Mexico facility closure
GrafTech International Ltd. revises cost estimates for closing its Monterrey facility, signaling a strategic operational shift.
Longeveron updates ELPIS II trial results for stem cell therapy
Longeveron Inc. announces updated results from its ELPIS II trial for laromestrocel, showing potential benefits for infants with hypoplastic left heart syndrome.
PennantPark Private Income Fund Reports Unregistered Sales
PennantPark Private Income Fund announces unregistered sales of equity securities, signaling potential growth and strategic initiatives in the private equity sector.
FirstSun Capital Bancorp Reports Strong Q3 Earnings Results
FirstSun Capital Bancorp announces Q3 2026 results, showing net income of $38.4 million, reflecting strong performance in the national commercial banking sector.
D.R. Horton appoints Carl E. Reichardt, Jr. as director
D.R. Horton, Inc. appoints Carl E. Reichardt, Jr. as an independent director, expanding its board and enhancing governance.
NewHydrogen, Inc. announces major share sale to SunHydrogen
NewHydrogen, Inc. enters a significant agreement with SunHydrogen, selling shares and warrants to strengthen its financial position.